Loading data
VIANYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2023 |
|---|---|---|---|---|
| Revenue | 434.34 m USD | 337.63 m USD | — | 248.85 m USD |
| Cost of revenue | 262.54 m USD | 206.79 m USD | — | 149.45 m USD |
| Gross profit | 171.8 m USD | 130.84 m USD | — | 99.41 m USD |
| Research and development expense | 92.35 m USD | 88.99 m USD | — | 95.83 m USD |
| Operating profit | -76.62 m USD | -83.9 m USD | — | -114.46 m USD |
| Profit before tax | -93.84 m USD | -88.66 m USD | — | -115.15 m USD |
| Income tax expense | 2.52 m USD | 1.89 m USD | — | 1.82 m USD |
| Net income (reported basis) | -96.36 m USD | -90.28 m USD | -116.96 m USD | -116.69 m USD |
| Net income attributable to common shareholders | -96.36 m USD | -90.28 m USD | — | -116.69 m USD |
| Basic earnings per share | -2.92 USD/share | -7.21 USD/share | — | -9.6 USD/share |
| Diluted earnings per share | -2.92 USD/share | -7.21 USD/share | — | -9.6 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.